This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Aclaris Therapeutics, Inc.. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2025
Title: David Gordon: Innovator in Immune Condition Treatments
Introduction
David Gordon is a notable inventor based in Ardmore, PA (US). He has made significant contributions to the field of medical treatments, particularly focusing on immune conditions. With a total of 2 patents, his work is recognized for its innovative approach to addressing inflammatory conditions.
Latest Patents
David Gordon's latest patents include oral compositions of MK2 pathway inhibitors for the treatment of immune conditions. The present disclosure relates to oral compositions of Compound I or a derivative thereof. Additionally, methods of use for treating inflammatory conditions are also disclosed in these patents.
Career Highlights
David Gordon is currently associated with Aclaris Therapeutics, Inc., where he continues to develop groundbreaking treatments. His work has been instrumental in advancing therapeutic options for patients suffering from immune-related issues.
Collaborations
One of his notable coworkers is Walter Smith, with whom he collaborates on various projects aimed at enhancing treatment methodologies.
Conclusion
David Gordon's contributions to the field of immune condition treatments through his innovative patents and work at Aclaris Therapeutics, Inc. highlight his commitment to improving patient care. His ongoing efforts in this area are paving the way for future advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile